Hyderabad Records India’s Highest Breast Cancer Rates: Dr. Sainath Bhethanabhotla Calls for Urgent Screening and Awareness

Hyderabad, (Telangana) [India] October 31, 2025: Breast cancer has emerged as the most common cancer among women in India, with Hyderabad recording the highest incidence rate—54 cases per 100,000 women. The national average stands at 26.6, marking a 21 percent rise over two decades. According to Dr. Sainath Bhethanabhotla, Senior Consultant & Head of Medical Oncology, Star Cancer Centre at Star Hospitals, Hyderabad, this sharp increase reflects a growing public-health challenge for urban India.

“The alarming rise in Hyderabad’s breast cancer rates highlights the urgent need for structured screening, awareness, and early intervention,” said Dr. Sainath Bhethanabhotla.

A Concerning Urban Trend

While the USA continues to report stable incidence rates of around 130–134 per 100,000 women—supported by widespread screening—India’s rates are climbing steadily. Hyderabad has now overtaken other major metros like Bengaluru (46.7), Chennai (45.4), Delhi (38.6), and Mumbai (34.4).

Dr. Bhethanabhotla explains that the difference lies not just in lifestyle but also in early detection. “In the US, almost 70–80 percent of cases are diagnosed early, ensuring over 90 percent survival. In India, nearly 60 percent of women reach hospitals only in advanced stages, where survival drops drastically,” he noted.

Changing Urban Lifestyle and Reproductive Patterns

Rapid urbanization has altered women’s reproductive and lifestyle patterns—one of the strongest risk factors behind rising breast cancer cases.

• Late Childbirth: Women having their first child after the age of 30 face a significantly higher risk. Each year’s delay raises the likelihood of developing hormone-driven breast cancers.
• Nulliparity (no childbirth): Women who never conceive lose the natural protective benefit of early pregnancy and extended breastfeeding.
• Declining Breastfeeding: Although India’s national breastfeeding rate remains 58 percent, urban areas like Hyderabad report far lower numbers—sometimes below 40 percent. Breastfeeding helps reduce lifetime estrogen exposure, lowering cancer risk.
• Obesity and Physical Inactivity: NFHS-5 data shows 30 percent of women in Telangana are overweight or obese. Obesity elevates estrogen levels, worsens cancer progression, and is linked to late-stage detection.
• Circadian Rhythm Disruption: Increasing numbers of women in IT and service sectors work late or night shifts. “Disturbed sleep patterns and reduced melatonin levels are now proven biological risk factors,” Dr. Bhethanabhotla pointed out.

Environmental and Dietary Impact

Hyderabad’s growing pollution levels also play a role. Studies show an 8 percent increase in breast cancer incidence for every 10 µg/m³ rise in PM2.5 exposure. With Hyderabad consistently crossing safe limits, women face prolonged exposure to carcinogens from traffic, industrial emissions, and biomass burning.

Dietary transitions—shifting from traditional fiber-rich foods to high-fat, processed diets—further compound the risk. “Urban diets rich in refined sugars, fats, and alcohol not only contribute to obesity but directly increase circulating estrogen levels,” said Dr. Sainath Bhethanabhotla. Even moderate alcohol use (one drink per day) raises breast-cancer risk by up to 10 percent, while heavier use can increase it by 20 percent.

Genetic and Molecular Factors

Genetic susceptibility adds another layer of risk. Studies indicate a higher prevalence of BRCA1 and BRCA2 mutations in Indian populations—sometimes up to 29 percent in high-risk families—compared to Western nations. Women with these mutations face up to a 70 percent lifetime risk of developing breast cancer.

In addition, Triple-Negative Breast Cancer (TNBC)—an aggressive subtype that does not respond to hormone therapy—accounts for nearly 30 percent of Indian cases, compared to 10–15 percent in Western countries. “We often see younger women in India affected by TNBC, which progresses faster and has fewer targeted treatment options,” added Dr. Bhethanabhotla.

Estrogen: The Double-Edged Hormone

Estrogen plays a critical role in normal breast-tissue growth, but prolonged or excessive exposure can be harmful. Early onset of menstruation, late menopause, delayed childbirth, obesity, and hormone-replacement therapy all increase lifetime estrogen exposure.

“Estrogen doesn’t just promote tumor growth—it can also trigger genetic mutations in breast cells,” explained Dr. Sainath Bhethanabhotla, emphasizing the importance of hormonal balance through healthy diet, exercise, and preventive screening.

The Screening Gap: A Missed Lifeline

Perhaps the most concerning gap lies in screening and early detection. Only 2 percent of women in Hyderabad and 1.3 percent nationally undergo mammography, compared to 70–84 percent in the USA. This lack of early diagnosis results in late-stage detection for 50–70 percent of Indian women.

“Screening is the single most effective tool to save lives,” said Dr. Bhethanabhotla. “The five-year survival for breast cancer decreases from 95 percent in Stage 1 to just 21 percent in Stage 4 — and most of these advanced-stage cases become incurable. Regular mammograms after 40 can make all the difference.”

Multiple barriers hinder screening in India—limited facilities, high costs, cultural stigma, and fear of diagnosis. Many women delay visiting doctors even after noticing lumps, leading to poorer outcomes.

From Awareness to Action

While prevention is complex, awareness is achievable. Dr. Sainath Bhethanabhotla urges a collective response:

• Individuals: Understand risk factors, perform monthly self-breast exams, maintain a healthy weight, and prioritize regular check-ups.
• Communities: Build awareness through schools, offices, and local women’s networks.
• Government: Invest in mobile screening units, subsidize mammography, and train female health workers to conduct preliminary screenings.

“Ignorance is no longer an option. Hyderabad’s data should serve as a wake-up call for the nation. Awareness is the foundation of survival,” said Dr. Bhethanabhotla.

About Star Hospitals

Star Hospitals, Hyderabad, is one of South India’s premier tertiary-care centers, offering advanced diagnostics, comprehensive cancer care, and multi-specialty services. Under the leadership of Dr. Sainath Bhethanabhotla, the hospital’s oncology program focuses on early detection, personalized treatments, and holistic support for patients and their families. Star Hospitals continues to drive awareness and preventive-health initiatives across Telangana, ensuring more women detect breast cancer early and live healthier lives.

For More Details Please contact: 07969250191, www.starhospitals.in